MalcovatiL, GermingU, KuendgenA, et al.: Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol, 2007; 25:3503–3510.
2.
GaleRP, BarosiG, BarbuiT, et al.: What are RBC-transfusion-dependence and -independence?. Leuk Res, 2011; 35:8–11.
3.
PrestonNJ, HurlowA, BrineJ, BennettMI: Blood tranfusions for anemia in patients with advanced cancer. Cochrane Database Syst Rev, 2012; 2:CD009007.
4.
KnutA, GardnerFH: Survival of blood platelets labeled with chromium. J Clin Invest, 1958; 37:1257–1268.
5.
KaufmanRM, DjulbegovicB, et al.: Platelet transfusion: A clinical practice guideline from the AABB. Ann Int Med, 2015; 162:205–213.
6.
GoksuSS, GunduzS, UnalD, et al.: Use of blood transfusion at the end of life: Does it have any effects on survival of cancer patients?. Asian Pac J Cancer Prev, 2014; 15:4251–4254.
7.
PlatzbeckerU, HofbauerLC, EhningerG, HoligK: The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes. Leuk Res, 2012; 36:525–536.
8.
GoldbergSL, ChenE, CorralM, et al.: Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol, 2010; 28:2847–2852.
9.
BartoszkoJ, PanzarellaT, LauA, et al.: Effect of Red Blood Cell Transfusion Dependence on the natural history of myeloproliferative neoplasm-associated myelofibrosis. Clin Lymphoma Myeloma Leuk, 2015; 15:e151–e156.
10.
SzendeA, SchaeferC, GossTF, et al.: Valuation of transfusion-free living in MDS: Results of health utility interviews with patients. Health Qual Life Outcomes, 2009; 7:81.
11.
OlszewskiAJ, EganPC, LeBlancTW: Transfusion dependence and use of Hospice among Medicare beneficiaries with Leukemia. Am Soc Hematol, 2017:277. 59th Annual Meeting and Exposition.
12.
FletcherSA, CroninAM, ZeidanAM, et al.: Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database. Cancer, 2016; 122:1209–1215.
